IMVT
Price
$33.49
Change
+$0.19 (+0.57%)
Updated
Sep 28 closing price
Capitalization
6.88B
51 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$23.67
Change
+$0.66 (+2.87%)
Updated
Sep 28 closing price
Capitalization
2.39B
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs NRIX

IMVT vs NRIX Comparison Chart in %
View a ticker or compare two or three
VS
IMVT vs. NRIX commentary
Sep 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Buy and NRIX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IMVT vs NRIX: Fundamental Ratings
IMVT
NRIX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
54100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4537
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NRIX's Valuation (46) in the null industry is in the same range as IMVT (50). This means that NRIX’s stock grew similarly to IMVT’s over the last 12 months.

IMVT's Profit vs Risk Rating (54) in the null industry is somewhat better than the same rating for NRIX (100). This means that IMVT’s stock grew somewhat faster than NRIX’s over the last 12 months.

IMVT's SMR Rating (98) in the null industry is in the same range as NRIX (98). This means that IMVT’s stock grew similarly to NRIX’s over the last 12 months.

NRIX's Price Growth Rating (37) in the null industry is in the same range as IMVT (45). This means that NRIX’s stock grew similarly to IMVT’s over the last 12 months.

NRIX's P/E Growth Rating (100) in the null industry is in the same range as IMVT (100). This means that NRIX’s stock grew similarly to IMVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTNRIX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
COMPARISON
Comparison
Sep 29, 2026
Stock price -- (IMVT: $33.30 vs. NRIX: $23.01)
Brand notoriety: IMVT and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 173% vs. NRIX: 129%
Market capitalization -- IMVT: $6.88B vs. NRIX: $2.39B
IMVT [@Biotechnology] is valued at $6.88B. NRIX’s [@Biotechnology] market capitalization is $2.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green while NRIX’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 4 bullish, 6 bearish.
  • NRIX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both IMVT and NRIX are a bad buy in the short-term.

Price Growth

IMVT (@Biotechnology) experienced а -9.88% price change this week, while NRIX (@Biotechnology) price change was -9.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was -7.16%, and the average quarterly price growth was +4.45%.

Reported Earning Dates

IMVT is expected to report earnings on Nov 18, 2026.

NRIX is expected to report earnings on Oct 09, 2026.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMVT
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RGYY5.790.03
+0.61%
GraniteShares YieldBoost RGTI ETF (RGYY)
QUS192.250.69
+0.36%
State Street SPDR MSCI USA StrategicFactors ETF (QUS)
ONDL5.730.02
+0.35%
Defiance Daily Target 2X Long ONDS ETF (ONDL)
TPHD41.130.07
+0.16%
Timothy Plan High Dividend Stock ETF (TPHD)
HIPS11.03-0.02
-0.14%
GraniteShares HIPS US High Income ETF (HIPS)

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-2.71%
KYMR - NRIX
58%
Loosely correlated
-3.33%
KURA - NRIX
46%
Loosely correlated
-0.92%
GPCR - NRIX
46%
Loosely correlated
-0.25%
BCYC - NRIX
45%
Loosely correlated
-1.21%
AGIO - NRIX
44%
Loosely correlated
-0.97%
More